Caplacizumab Completed Phase 2 Trials for Unstable Angina Pectoris / Stable Angina (Associated With High Risk PCI) / Non ST Segment Elevation Myocardial Infarction (NSTEMI) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01020383Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients